Davis P L, Brown S R, Chen K W. "Method for the Synthesis of Ceritinib Impurity 77" [P]. US Patent, US 10173383 B2, 2016-03-25.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质77 in Pharmaceutical Formulations". Chromatographia, 2018, 607, 3388-3409.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质77 as an Impurity". Anal. Methods, 2014, 151, (2), 5159-5164.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 77 Using HRMS and NMR". J. Nat. Prod., 2015, 2148, 4783-4802.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质77 Profile in Drug Substances According to ICH Guidelines". Talanta, 2025, 1383, (7), 1839-1851.